Knee Bracing No Benefit Over Nonoperative Program in Knee OA

This article originally appeared here.
Share this content:
Knee Bracing No Benefit Over Nonoperative Program in Knee OA
Knee Bracing No Benefit Over Nonoperative Program in Knee OA

TUESDAY, Nov. 17, 2015 (HealthDay News) -- For patients with knee osteoarthritis (OA), knee bracing offers no benefit over a multidisciplinary nonoperative program, according to a study published online Nov. 12 in the International Journal of Rheumatic Diseases.

Shirley P. Yu, M.D., from the Royal North Shore Hospital in St. Leonards, Australia, and colleagues examined the effectiveness of bracing treatment for tibiofemoral and patellofemoral OA within a 52-week multidisciplinary nonoperative program for OA patients. Two hundred four patients with symptomatic, radiographic knee OA were examined at weeks 0, 12, 26, and 52. Of the participants, 50 were assigned to patellofemoral bracing, 86 to tibiofemoral bracing, and 68 to no bracing.

The researchers found that the mean baseline Knee injury and Osteoarthritis Outcome Score (KOOS) pain scores were 52.9, 41.7, and 43.3 for patients with patellofemoral bracing, tibiofemoral bracing, and no bracing, respectively; the corresponding KOOS activities of daily living (ADL) scores were 55.8, 43.7, and 43.1. In each group there were significant improvements at week 52 for KOOS pain score and KOOS ADL. After adjustment for baseline variables there was no significant between-group difference in KOOS pain (P = 0.12) and ADL score (P = 0.13).

"A multidisciplinary nonoperative program improved pain and function in persons with patellofemoral and tibiofemoral OA," the authors write. "However, wearing a patellofemoral or a tibiofemoral brace did not appear to provide additional benefits."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

FDA Approves 'Artificial Pancreas' for Type 1 Diabetes

MiniMed 670G hybrid closed loop system automatically monitors glucose, delivers insulin

More Evidence HPV Vaccine Protects Against Cervical Cancer

More Evidence HPV Vaccine Protects Against Cervical Cancer

Protection appears to occur even when only one or two of the recommended doses are given

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Prescribed NSAIDs Tied to Higher Heart Failure Risk

Study of millions of health records suggests an association

is free, fast, and customized just for you!

Already a member?

Sign In Now »